Brace Pharma

Brace Pharma

Brace Pharma

Suggest edits
Follow us
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 7

Portfolio

Portfolio Tracker

Add info
$65,000,000 Venture capital (Series B)
FinSMEs

HotSpot Therapeutics Closes $65M Series B Financing

HotSpot Therapeutics
HotSpot Therapeutics
Xconomy

HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic

HotSpot Therapeutics
HotSpot Therapeutics
the home of AI info

Unum Therapeutics Inc. (UMRX)'s Financial Results Comparing With Minerva Neurosciences Inc ...

Unum Therapeutics
Unum Therapeutics
FinSMEs

Lilly and Avidity Biosciences Sign Licensing and Research Collaboration Deal

Avidity Biosciences
Avidity Biosciences
Undisclosed funding
FinSMEs

Avidity Biosciences Receives Equity Investment from CureDuchenne

Funding Health Science
Avidity Biosciences
Avidity Biosciences
$45,000,000 Venture capital (Series A)
PE HUB , FinSMEs

HotSpot Therapeutics scores $45 mln Series A

Data leaks Messaging
HotSpot Therapeutics
HotSpot Therapeutics
$99,700,000 IPO
PE HUB

VC-backed Avrobio rolls out IPO

Stock markets Health
AVROBIO
AVROBIO
$69,200,000 IPO
PE HUB

VC-backed Unum Therapeutics rolls out IPO

Stock markets Health
Unum Therapeutics
Unum Therapeutics
Xconomy

Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies

Health Stock markets
Unum Therapeutics
Unum Therapeutics
$60,000,000 Venture capital (Series B)
FinSMEs , Xconomy , MedCity News

Avrobio Raises $60M in Series B Financing

Health Funding
AVROBIO
AVROBIO
$15,000,000 Debt financing
FinSMEs

Unum Therapeutics Receives $15M Credit Facility from Square 1 Bank

Unum Therapeutics
Unum Therapeutics
Unum
Unum
$10,000,000 Venture capital (Series B)
biospace , PE Hub , prnewswire

Avidity Biosciences Raises 16 Million In Series B Financing To Advance Antibody Sirna Conjugate Platform

Avidity Biosciences
Avidity Biosciences
$40,000,000 Venture capital (Series D)
PE Hub

Miragen racks up $40 mln, will merge with Signal Genetics

miRagen Therapeutics
miRagen Therapeutics
$25,000,000 Venture capital (Series A)
businesswire

AVROBIO, Inc. Announces $25 Million Series A Financing to Advance Novel, Clinical-Stage Gene Therapies for Rare Diseases...

AVROBIO
AVROBIO
$33,000,000 Venture capital (Series B)
businesswire

Navitor Pharmaceuticals Announces $33 Million Series B Financing

Navitor Pharma
Navitor Pharma
$6,000,000 Venture capital (Series B)
PE Hub

Avidity NanoMedicines racks up $6 mln